https://www.sciencedaily.com/releases/2022/11/221109085756.htm
A definitive diagnosis of Alzheimer's disease (AD) was once only possible after someone had died, but recent biomarker studies have led to the development of imaging and spinal fluid tests for those still living. However, the tests can only monitor severe dis…
Create an account or login to join the discussion